Rabbit Recombinant Monoclonal SIGLEC10 antibody. Suitable for IHC-P, WB and reacts with Transfected cell line - Human, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IHC-P | WB | Flow Cyt (Intra) | IP | ICC/IF | |
---|---|---|---|---|---|
Human | Tested | Tested | Not recommended | Not recommended | Not recommended |
Mouse | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Transfected cell line - Human | Tested | Not recommended | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell line - Human | Dilution info 1/2000 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species Human | Dilution info 1/500 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Transfected cell line - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Transfected cell line - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Transfected cell line - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Transfected cell line - Human, Mouse, Rat | Dilution info - | Notes - |
Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- or alpha-2,6-linked sialic acid (By similarity). The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, seems to act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules (PubMed:11284738, PubMed:12163025). Involved in negative regulation of B-cell antigen receptor signaling. The inhibition of B cell activation is dependent on PTPN6/SHP-1 (By similarity). In association with CD24 may be involved in the selective suppression of the immune response to danger-associated molecular patterns (DAMPs) such as HMGB1, HSP70 and HSP90 (By similarity). In association with CD24 may regulate the immune repsonse of natural killer (NK) cells (PubMed:25450598). Plays a role in the control of autoimmunity (By similarity). During initiation of adaptive immune responses by CD8-alpha(+) dendritic cells inhibits cross-presentation by impairing the formation of MHC class I-peptide complexes. The function seems to implicate recruitment of PTPN6/SHP-1, which dephosphorylates NCF1 of the NADPH oxidase complex consequently promoting phagosomal acidification (By similarity).
SIGLEC11
SLG2, UNQ477/PRO940, SIGLEC10, Sialic acid-binding Ig-like lectin 10, Siglec-10, Siglec-like protein 2
Rabbit Recombinant Monoclonal SIGLEC10 antibody. Suitable for IHC-P, WB and reacts with Transfected cell line - Human, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB signal is only observed in tissue lysates.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
SIGLEC10 and SIGLEC11 are members of the sialic acid-binding immunoglobulin-type lectins family also known as siglecs. SIGLEC10 sometimes called CD33L1 has an approximate molecular mass of 85 kDa. SIGLEC11 has a molecular mass of about 101 kDa. These proteins are transmembrane receptors involved in cellular signaling. SIGLEC10 is expressed in various tissues including the placenta and spleen while SIGLEC11 expression is found mainly in the microglia of the brain. Their primary role is to mediate interactions with sialylated glycan ligands which affects cell-cell communication.
SIGLEC10 and SIGLEC11 play important roles in the immune response by regulating inflammatory processes and helping the body distinguish between self and non-self cells. They function as part of the immune system to modulate immune cell activation damping down potentially harmful overreactions. These proteins can inhibit immune cell signaling when they engage with sialic acid-containing structures representing a form of immune checkpoint control. Their involvement in dampening inflammatory responses makes them part of the innate immune complex important in maintaining tissue homeostasis.
SIGLEC10 and SIGLEC11 both interact with immunoregulatory pathways like the CD33-related and B cell receptor signaling pathways. Through these pathways they are involved in controlling immune responses and maintaining cellular communication balance. SIGLEC10 shows relationship with proteins such as SHP-1 and SHP-2 which are phosphatases that play critical roles in signal transduction. SIGLEC11 however interacts within microglial function pathways involving proteins associated with the innate immune response.
SIGLEC10 and SIGLEC11 connect to conditions such as Alzheimer's disease and rheumatoid arthritis. In Alzheimer’s SIGLEC11 interaction with microglia influences the disease's neuroinflammatory component. Its role can help modulate the immune environment in the brain influencing disease progression. SIGLEC10’s dysfunctional regulation may contribute to the chronic inflammation observed in rheumatoid arthritis often mediated by aberrant immune responses. This relation involves other siglec family members like SIGLEC9 which together modulate inflammatory pathways.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Negative control: human skeletal muscle (PMID:11733002).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-SIGLEC10 + SIGLEC11 antibody [EPR29036-83] (ab317448) at 1/1000 dilution
Lane 1: Human tonsil tissue lysate at 20 µg with NFDM/TBST
Lane 2: Human spleen tissue lysate at 20 µg with NFDM/TBST
Lane 3: Human skeletal muscle tissue lysate at 20 µg with NFDM/TBST
All lanes: Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 76 kDa, 36 kDa
Exposure time: 103s
Immunohistochemical analysis of paraffin-embedded (A) HEK-293T (human epithelial cell line from embryonic kidney) transfected with a SIGLEC10 expression vector containing a Myc-His tag. (B) HEK-293T transfected with a SIGLEC11 expression vector containing a Myc-His tag. (C) HEK-293T transfected with a SIGLEC16 expression vector containing a Myc-His tag. (D) HEK-293T transfected with a SIGLEC5 expression vector containing a Myc-His tag. (E) HEK-293T transfected with empty vector containing a Myc-His tag. tissue labeling SIGLEC10 + SIGLEC11 with ab317448 at 1/2000 (0.251 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
This antibody recognizes both SIGLEC10 and SIGLEC11. Positive staining on (A) HEK-293T (human epithelial cell line from embryonic kidney) transfected with a SIGLEC10 expression vector containing a Myc-His tag and (B) HEK-293T transfected with a SIGLEC11 expression vector containing a Myc-His tag, negative staining on (C) HEK-293T transfected with a SIGLEC16 expression vector containing a Myc-His tag, (D) HEK-293T transfected with a SIGLEC5 expression vector containing a Myc-His tag and (E) HEK-293T transfected with empty vector containing a Myc-His tag. The section was incubated with ab317448 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labeling SIGLEC10 + SIGLEC11 with ab317448 at 1/500 (1.004 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Negative control: no staining on human skeletal muscle. The section was incubated with ab317448 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Immunohistochemical analysis of paraffin-embedded Human endometrial carcinoma tissue labeling SIGLEC10 + SIGLEC11 with ab317448 at 1/500 (1.004 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human endometrial carcinoma. The section was incubated with ab317448 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling SIGLEC10 + SIGLEC11 with ab317448 at 1/500 (1.004 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human tonsil. The section was incubated with ab317448 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Immunohistochemical analysis of paraffin-embedded Human spleen tissue labeling SIGLEC10 + SIGLEC11 with ab317448 at 1/500 (1.004 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on human spleen (PMID: 11358961; PMID: 11284738; PMID: 11733002). The section was incubated with ab317448 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com